Robert T. Weibert, PharmD; Dzung The Le, MD, PhD; Steven R. Kayser, PharmD; Samuel I. Rapaport, MD
Despite earlier acceptance of oral vitamin K1 (phytonadione) for the treatment of excessive anticoagulation, some recent guidelines do not recommend its use.
To reevaluate the efficacy of oral vitamin K1 in correcting excessive anticoagulation.
Anticoagulation clinics at two university medical centers.
81 outpatients who had an international normalized ratio (INR) greater than 5.0 but did not have significant bleeding.
Withholding 1 or 2 doses of warfarin, administering 2.5 mg of oral vitamin K1, measuring the INR after 24 to 48 hours, and adjusting the warfarin dose.
INRs were obtained from a portable capillary fingerstick monitor or from an automated photooptical coagulometer.
In 68 of 71 patients (96%), oral vitamin K1 lowered the INR from between 5.0 and 10.0 to less than 5.0 without inducing resistance to further anticoagulation.
Withholding 1 or 2 doses of warfarin and administering 2.5 mg of oral vitamin K1 is a reliable, safe, and inexpensive way to rapidly correct excessive anticoagulation (INR > 5.0) in patients who do not have serious bleeding episodes and have an INR of less than 10.0.
Weibert RT, The Le D, Kayser SR, Rapaport SI. Correction of Excessive Anticoagulation with Low-Dose Oral Vitamin K1. Ann Intern Med. 1997;126:959–962. doi: 10.7326/0003-4819-126-12-199706150-00005
Download citation file:
Published: Ann Intern Med. 1997;126(12):959-962.
Acute Coronary Syndromes, Biliary Disorders, Cardiology, Coagulopathies, Coronary Heart Disease.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use